TIGERMED (03347.HK): Directors and Controlling Shareholders Ye Xiaoping and Cao Xiaochuan Placed Under CSRC Investigation

NewTimeSpace News: Hangzhou Tigermed Consulting Co., Ltd. (03347.HK) released an inside information announcement on May 12, 2026. The Company learned that Mr. Ye Xiaoping and Ms. Cao Xiaochuan, Directors and Controlling Shareholders, received case filing notices issued by the China Securities Regulatory Commission (CSRC).

They are suspected of committing information disclosure irregularities concerning the Company’s shareholding changes. In accordance with the Securities Law of the People’s Republic of China and the Administrative Penalty Law of the People’s Republic of China, the CSRC has decided to launch a formal investigation into the two parties. Mr. Ye and Ms. Cao will fully cooperate with the CSRC and comply with regulatory information disclosure obligations.

The Board of Directors stated that the Group’s daily business operations remain stable, and the aforesaid investigation will not impact normal operation.

NewTimeSpace Disclaimer: All content herein is the original work of NewTimeSpace. Any reproduction, reprinting, or use of this content in any other manner must clearly indicate the source as "NewTimeSpace". NewTimeSpace and its authorized third-party information providers strive to ensure the accuracy and reliability of the data, but do not guarantee the absolute correctness thereof. This content is for reference only and does not constitute any investment advice. All transaction risks shall be borne by the user.